Company intelligence / Profile preview

NTNU Technology Transfer

Trondheim, Norway
Ownership
Private
Employees
~35
Development stage
Other
01

Overview

NTNU Technology Transfer AS (NTNU TTO) is the commercialization arm of the Norwegian University of Science and Technology and the Central Norway Regional Health Authority. The organization identifies, evaluates, and develops research-based innovations with commercial potential, specializing in intellectual property management, licensing, and the creation of spin-off companies. In the life sciences sector, NTNU TTO manages a diverse portfolio of technologies ranging from novel therapeutic modalities and diagnostics to advanced medical devices. They provide researchers with business development expertise, seed funding through the NTNU Discovery program, and access to an extensive international network of investors and industry partners. Notable life science spin-offs from their portfolio include APIM Therapeutics, Vectron Biosolutions, and Serca Pharmaceuticals.

Therapeutic areas
ImmunologyCardiovascularDermatologyInfectious DiseasesOncology
Modalities
Small moleculePeptidesRecombinant proteinMedical DeviceDiagnosticsAntibodyCell therapy
Industry
Academic Hospital/University/Research
02

Partnerships

Helse Midt-NorgeSINTEFEquinorNorges forskningsrådCoegin Pharma

Beyond the preview

Go deeper on NTNU Technology Transfer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NTNU Technology Transfer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call